Harmony Biosciences Holdings, Inc. (HRMY)

Longboard Pharmaceuticals Revenue

Harmony Biosciences Holdings had revenue of $200.49M in the quarter ending June 30, 2025, with 16.01% growth. This brings the company's revenue in the last twelve months to $772.53M, up 17.74% year-over-year. In the year 2024, Harmony Biosciences Holdings had annual revenue of $714.73M with 22.80% growth.

• Revenue (ttm): $772.53M
• Revenue Growth: +17.74%
• P/S Ratio: 2.53
• Revenue / Employee: $2,882,563
• Employees: 268
• Market Cap: 1.97B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	714.73M	132.71M	22.80%
Dec 31, 2023	582.02M	144.17M	32.93%
Dec 31, 2022	437.86M	132.42M	43.35%
Dec 31, 2021	305.44M	145.70M	91.21%
Dec 31, 2020	159.74M	153.75M	2,564.59%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.